Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Preparing nurse scientists for health services and policy research: Five-year outcomes of interprofessional postdoctoral training in the National Clinician Scholars Program.

Choi KR, Brush BL, Chapman SA, Costa DK, Feder SL, Gutierrez JI, Heilemann MV, Manojlovich M, Noonan D, Park LG, Potempa K, Sochalski J

Nurs Outlook 2023 Jul doi: 10.1016/j.outlook.2023.102024

Towards equity in paediatric liver transplantation: improving access and long-term outcomes.

Wadhwani SI, Kumar WM, Hsu EK

Lancet Gastroenterol Hepatol 2023 Jul doi: 10.1016/S2468-1253(23)00099-7

Biodistribution of Lipid 5, mRNA, and Its Translated Protein Following Intravenous Administration of mRNA-Encapsulated Lipid Nanoparticles in Rats.

Ci L, Hard M, Zhang H, Gandham S, Hua S, Wickwire J, Wehrman T, Slauter R, Auerbach A, Kenney M, Mercer G, Hendrick T, Almarsson Ö, Cheung E, Burdette D

Drug Metab Dispos 2023 Jul doi: 10.1124/dmd.122.000980

Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial.

Feld JJ, Wahed AS, Fried M, Ghany MG, Di Bisceglie AM, Perrillo RP, Khalili M, Yang X, Belle SH, Janssen HLA, Terrault N, Lok AS, Hepatitis B Research Network (HBRN)

Am J Gastroenterol 2023 Jul doi: 10.14309/ajg.0000000000002176

Using Modern Modalities to Improve Population Health and Advance Food and Health Equity-Reply.

Virudachalam S, Kim LS, Seligman H

JAMA Pediatr 2023 Jul doi: 10.1001/jamapediatrics.2023.1339

Successful mentorship for women in urology - a new era.

Suskind AM, Tanaka S

Nat Rev Urol 2023 Jul doi: 10.1038/s41585-023-00745-y

Immediate Open Access: The Good, the Bad, and the Impact on Academic Society Publishing.

Sawalha AH, Solomon DH, Allen KD, Katz P, Yelin E

Arthritis Care Res (Hoboken) 2023 Jul doi: 10.1002/acr.25131

ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.

Wang M, Slatter S, Sussell J, Lin CW, Ogale S, Datta D, Butte AJ, Bazhenova L, Rudrapatna VA

Target Oncol 2023 Jul doi: 10.1007/s11523-023-00973-7

Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: Effectiveness and value.

McKenna A, Lin GA, Whittington MD, Nikitin D, Herron-Smith S, Campbell JD, Agboola F, Pearson SD

J Manag Care Spec Pharm 2023 Jul doi: 10.18553/jmcp.2023.29.7.857

Monitoring and Achievement of Target Serum Urate Among Gout Patients Receiving Long-Term Urate-Lowering Therapy in the American College of Rheumatology RISE Registry.

Hammam N, Li J, Kay J, Izadi Z, Yazdany J, Schmajuk G

Arthritis Care Res (Hoboken) 2023 Jul doi: 10.1002/acr.25009